EXELIXIS, INC. — Director's Dealing 2019

Jan 5, 2019

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: EXELIXIS, INC. (EXEL)
CIK: 0000939767
Period of Report: 2019-01-02

Reporting Person: MORRISSEY MICHAEL (Director, President and CEO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2018-11-27	Common Stock	G	17647	—	Disposed	90000	Direct
2018-11-27	Common Stock	G	17647	—	Acquired	193998	Indirect
2019-01-02	Common Stock	M	6046	$5.56	Acquired	96046	Direct
2019-01-02	Common Stock	S	6046	$20	Disposed	90000	Direct
2019-01-03	Common Stock	M	3571	$5.56	Acquired	93571	Direct
2019-01-03	Common Stock	S	3571	$20	Disposed	90000	Direct
2019-01-04	Common Stock	M	30383	$5.56	Acquired	120383	Direct
2019-01-04	Common Stock	S	30383	$20.14	Disposed	90000	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2019-01-02	Common Stock	$5.56	M	6046	Disposed	2019-09-20	Common Stock (6046.0)	Direct
2019-01-03	Common Stock	$5.56	M	3571	Disposed	2019-09-20	Common Stock (3571.0)	Direct
2019-01-04	Common Stock	$5.56	M	30383	Disposed	2019-09-20	Common Stock (30383.0)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	17354	Indirect

Footnotes

F1: On November 27, 2018, the reporting person gifted 17,647 shares to Michael M. Morrissey and Meghan D. Morrissey, Trustees of the Morrissey Family Trust dated July 21, 1994, as amended.

F2: Includes 90,000 shares of Exelixis, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units.

F3: Shares held by Michael M. Morrissey and Meghan D. Morrissey, Trustees of the Morrissey Family Living Trust dated July 21, 1994, as amended.

F4: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 29, 2018.

F5: Represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $20.00 to $20.38. Reporting Person undertakes to provide Exelixis, Inc., any security holder of Exelixis, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote 5 to this Form 4.

F6: Represents shares of Exelixis, Inc. common stock under the Exelixis, Inc. 401(k) Plan, pursuant to a plan statement dated as of January 2, 2019.

F7: The option, representing the right to purchase a total of 402,000 shares of Exelixis, Inc. common stock, became fully exercisable on September 21, 2016.